FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE, http:// www.unigene.com), a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs, has been included in the Scrip World Pharmaceutical News “Company League Tables” ranking of the top fifty biotechnology companies in the world ranked by 2007 sales of pharmaceutical products. In the October 31, 2008, edition of the publication, Unigene ranked number thirty-three in the listing, with $12.76 million in sales, representing an increase of over 350% from 2006. Unigene ranked 18th among US-based companies. The executive briefing also singled out Unigene as one of a handful of companies that “reported significantly increased sales for 2007 compared with the previous year.”
